• No results found

Implementation of geriatric assessment and decision support in residential care homes: facilitating and impeding factors during initial and maintenance phase

N/A
N/A
Protected

Academic year: 2020

Share "Implementation of geriatric assessment and decision support in residential care homes: facilitating and impeding factors during initial and maintenance phase"

Copied!
9
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Opinion staff and family physicians of intervention homes (n = 5) on multidisciplinary integrated careresearch question 1
Table 3 Benefits of the interRAI-LTCF according to staff (n = 6) of 3 homes
Table 5 Benefits according to the management (n = 3) of 3 homes during maintenance phase
Table 7 Impeding and facilitating factors during maintenance according to managers (n = 3) and staff (n = 6) of thebest, the worst and an about average scoring home according interRAI-LTCF outcomes (n = 3)

References

Related documents

innovation in payment systems, in particular the infrastructure used to operate payment systems, in the interests of service-users 3.. to ensure that payment systems

This was achieved by enhancing the work in [8]through the addition of a robust and secure database management system; [9] through securing patrons

In general, this equation, with or without some modification, applies to all other type of osmotic systems. Several simplifications in Rose-Nelson pump were made by Alza

This essay asserts that to effectively degrade and ultimately destroy the Islamic State of Iraq and Syria (ISIS), and to topple the Bashar al-Assad’s regime, the international

The projected gains over the years 2000 to 2040 in life and active life expectancies, and expected years of dependency at age 65for males and females, for alternatives I, II, and

Subject Matter Expert – Oracle OAAM and IDM Setup Design and Implementation (Each Master Contractor can only submit three candidate for the RFR).. Anticipated start date June

[16] El Gnaoui T, Dupuis J, Belhadj K: Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates